Development of Cagrilintide, a Long Acting Amylin Analogue Journal of Medicinal Chemistry Amylin, Another Important Neuroendocrine Hormone for the Treatment of Diabesity Amylin: From Mode of Action to Future Clinical Potential in Diabetes and Obesity Diabetes Therapy Springer Nature Link Novo Nordisk presents new Phase III data for next gen amylin cagrilintide The Pharmaletter Amylin Injectable Cagrilintide Demonstrates Weight Loss of 11.8% in Late Stage Trial: Novo Nordisk Update Patient Care Online Does receptor balance matter? Comparing the efficacies of the dual amylin and calcitonin receptor agonists cagrilintide and KBP 336 on metabolic parameters in preclinical models ScienceDirect